Dr. Basler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8300 Floyd Curl Dr
Fl 4
San Antonio, TX 78229Phone+1 210-450-9600Fax+1 210-450-9656
Summary
- Dr. Joseph Basler is an academic urologist in San Antonio, TX and is affiliated with multiple hospitals in the area, including University Health System, and UT Health San Antonio MD Anderson Cancer Center. He serves as the Program Director at UT Health San Antonio, Department of Urology. He received his medical degree from University of Missouri-Columbia School of Medicine and has been in practice 30 years. He specializes in stone disease and urologic oncology and is experienced in oncology, endourology and stone disease and urologic infections.
Clinical Expertise
- Urologic oncology, Kidney and ureteral stones
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Urology, 1986 - 1990
University of Missouri-ColumbiaResidency, Surgery, 1984 - 1986
University of Missouri-Columbia School of MedicineClass of 1984
Certifications & Licensure
MO State Medical License 1986 - 2025
TX State Medical License 1999 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Surgery in Treating Patients With Prostate Cancer Start of enrollment: 1997 May 01
- S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Start of enrollment: 2007 Sep 01
- Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 16 citationsTolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancer.Gregory P. Swanson, William E. Jones, Chul S. Ha, Carol A. Jenkins, Addanki P. Kumar
Phytotherapy Research. 2015-01-01 - 736 citationsDetection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.William J. Catalona, Deborah S. Smith, Timothy L. Ratliff, Joseph W. Basler
JAMA. 1993-08-25 - 179 citationsThe association of body mass index and prostate-specific antigen in a population-based study.Jacques Baillargeon, Brad H. Pollock, Alan R. Kristal, Patrick T. Bradshaw, Javier Hernandez
Cancer. 2005-03-01
Professional Memberships
- American Urologic AssociationMember
External Links
- UT Medicine Urologyhttp://urology.uthscsa.edu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
